Drug Research

Global research consortium is being set up to address the international impact of antimicrobial resistance (AMR). Significantly, the Centres for Antimicrobial Optimisation Network- CAMO-Net brings together research team from South Africa’s University of Cape Town, the University of Liverpool...

It is still difficult to get to the bottom of viral illnesses. Although isolated medicines exist that block virus multiplication in human cells, they are a significant exception. Against this backdrop, Prof. Reinhard Klein's from IMC Krems' Department of...

Research co-led by the University of Queensland has found that Australia is falling short of similar countries when it comes to funding basic research, specifically in the medical, biotechnology, and pharmaceutical arenas. The University of Queenland’s School of Chemical...

R21/Matrix-M happens to have a saponin-based adjuvant, Matrix-M, which goes on to enhance the immune response, thereby making it more viable and also durable. It is well to be noted that the adjuvant stimulates the entry of the antigen-presenting cells...

A novel study by researchers at Uppsala University as well as its hospital has shown that men who happen to have a neurodevelopmental disorder like autism or ADHD have a higher risk of show this kind of link. It has...

Numerous disease-causing bacteria like Streptococcus pneumoniae, happen to be encased in a sugar layer that is known as the capsular polysaccharide (CPS). This layer is often essential when it comes to infections. In a discovery that can indeed be termed...

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK. Part of Upperton’s £15m investment program announced in January this year, the state-of-the-art...